JAZZ - Company ID 0001232524
As of 2026-11-06, Jazz Pharmaceuticals plc (JAZZ) has a market capitalization of $14.84 B, making it the #741 most valuable US-listed company.
| Date | Market cap |
|---|---|
| 2026-11-06 | $14.84 B |
| 2026-11-05 | $14.40 B |
| 2026-11-04 | $14.65 B |
| 2026-11-03 | $14.41 B |
| 2026-11-02 | $13.54 B |
| 2026-11-01 | $13.55 B |
| 2026-10-31 | $13.55 B |
| 2026-10-30 | $13.44 B |
| 2026-10-29 | $12.92 B |
| 2026-10-28 | $12.87 B |
| 2026-10-27 | $12.97 B |
| 2026-10-26 | $12.91 B |
As of 2026-11-06, Jazz Pharmaceuticals plc (JAZZ) has a market capitalization of $14.84 B, making it the #741 most valuable US-listed company.
Jazz Pharmaceuticals plc is the #741 largest US-listed company by market capitalization.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| 2026-10-25 | $13.43 B |
| 2026-10-24 | $13.43 B |
| 2026-10-23 | $13.43 B |
| 2026-10-22 | $13.47 B |
| 2026-10-21 | $13.30 B |
| 2026-10-20 | $13.41 B |
| 2026-10-19 | $13.08 B |
| 2026-10-18 | $13.19 B |
| 2026-10-17 | $13.19 B |
| 2026-10-16 | $13.15 B |
| 2026-10-15 | $13.45 B |
| 2026-10-14 | $13.15 B |
| 2026-10-13 | $13.25 B |
| 2026-10-12 | $13.63 B |
| 2026-10-11 | $13.70 B |
| 2026-10-10 | $13.70 B |
| 2026-10-09 | $13.70 B |
| 2026-10-08 | $14.04 B |
Readings accumulate daily as market data refreshes, combining SEC-reported share counts with live prices.